NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis
about
Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old playerCyclosporin A induces cardiac differentiation but inhibits hemato-endothelial differentiation of P19 cellsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasGenome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.Store-operated CRAC channels regulate gene expression and proliferation in neural progenitor cells.PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization.ERK activation is required for CCK-mediated pancreatic adaptive growth in mice.OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.Activation of cytosolic phospholipase A2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C γ (PKCγ) signaling axis is required for hypoxia-induced pathological retinal angiogenesisProtein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodelingNeonatal β cell development in mice and humans is regulated by calcineurin/NFATNuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall reVein graft failure.Wnt signaling in cardiovascular disease: opportunities and challenges.Estrogen controls embryonic stem cell proliferation via store-operated calcium entry and the nuclear factor of activated T-cells (NFAT).CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells.The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.LIM and cysteine-rich domains 1 is required for thrombin-induced smooth muscle cell proliferation and promotes atherogenesis.Effects of OX40-OX40L interaction on the nuclear factor of activated T cells c1 in ApoE-deficient mice.
P2860
Q26751243-3A9BAE63-3D0E-4E56-946E-1A46689145D0Q27316115-9ADED15A-5ABD-431E-B74E-03495F1A50A3Q28567562-86392FC6-127E-4B8E-A76D-A30B7A89DF7AQ30424180-B73E6817-45C8-4FAB-8E4A-50259ECB2A6AQ30424684-09EA3DA1-3264-4CA8-8167-289485436461Q30433341-5FACEF2A-A937-485A-B767-F3CBB1645A3EQ33661435-8A1CB05A-1C15-4331-B56D-A1B87A5C1396Q33832147-96188E56-8A0F-4084-8287-7536BA299297Q34122706-8D8228DB-F88B-4A44-8DC2-02AEFDD9A91CQ34295427-983682C3-5C0B-4E4C-9293-2643B16E3552Q34674266-2A4EBFD3-DF7D-453E-A6D6-9FD9E8C4A347Q35063138-0868003E-84C2-4E96-A08E-B4E210A1D4ACQ36332889-8BCC34CF-3E74-438F-8564-E545F2923B84Q36655088-E2396A7E-2EB7-43CD-9C82-3B7228B964A7Q37048514-00B95EB9-5060-482A-A68E-7CD53FF24A14Q38149507-0C2B677C-7BB9-4F0E-BCED-B7803A8091D1Q39445406-F2BB3688-F225-48F7-A2EA-93DA7779CF46Q39478396-02AECFBC-6759-42B4-B25D-6909C919CFC5Q40096899-C7FF7B8C-C0D0-4BB7-823B-388A65BC9ABBQ43159115-1BBC4DF4-40EC-4B3E-B48F-F75B75EEF29BQ43409987-2ADEF3E1-9165-4A5D-AF66-77F0FCB3964EQ50078162-38D2F5B3-2E60-41A9-8469-BC345EEA8DB8Q54242938-FC51EA35-268E-453C-8B8B-EC0F473039BA
P2860
NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis
description
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2008
@ast
im September 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/09/26)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/09/26)
@nl
наукова стаття, опублікована у вересні 2008
@uk
name
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@ast
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@en
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@nl
type
label
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@ast
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@en
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@nl
prefLabel
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@ast
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@en
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@nl
P2093
P2860
P3181
P356
P1476
NFATc1 targets cyclin A in the ...... ltiplication during restenosis
@en
P2093
Gadiparthi N. Rao
Manjula Karpurapu
Nikhlesh K. Singh
P2860
P304
26577–26590
P3181
P356
10.1074/JBC.M800423200
P407
P577
2008-09-26T00:00:00Z